at the medical office Bangkok Mr. Chatchart Sitthiphan, Governor of Bangkok presided over the signing Cooperation to expand the project “Don’t Wait. Get Checked.”
Between Bangkok and AstraZeneca (Thailand) Company Limited, the Don’t Wait. Get Checked. project aims to expand access to medical services and treatment. Ready to increase efficiency in screening lung cancer Initially, with the use of artificial intelligence (AI) technology throughout Bangkok.
This cooperation between AstraZeneca Thailand and Bangkok is considered to continue the goal of increasing Five-year survival rate of patients to double by 2025 of the Lung Ambition Alliance (LAA), a joint effort between four international partners: AstraZeneca, the Global Lung Cancer Coalition (GLCC), Guardant Health and International. The Association for the Study of Lung Cancer (IASLC) conducts activities to support its mission in 50 countries around the world. Including Thailand To study and understand the evolution of the disease. Develop advanced techniques in disease care “lung cancer”
.
Use AI technology to help develop screening tests.
.
Through the promotion of initial screening for lung cancer. To increase the chances of effective early detection using AI technology, which will allow patients to live longer. Including having a better quality of life, cancer is the number 1 cause of death in Thailand with a death rate of over 80,000 people per year, with lung cancer being the number one cause of death.
Lung cancer is one of the cancer groups in which patients are usually diagnosed in stage 4, which is the final stage. As a result, the treatment is not as effective as it should be. Therefore, using AI technology to help develop basic lung cancer screening tests. It is very important. For this reason, AstraZeneca Thailand continues operations under the Don’t Wait. Get Checked. project.
We have collaborated with government and private agencies to use AI technology in primary lung cancer screening for more than 7,000 cases. There were 586 patients with suspected lung nodule lesions, accounting for 8%, who found suspicious lung nodule lesions. which has a high probability of having lung cancer, up to 0.3 percent as well
.
Bangkok hopes to see timely access to treatment.
.
Mr. Chatchat Sitthiphan, Governor of Bangkok (Bangkok), said that creating good health good public health system And reducing health impacts for the people is an urgent matter that Bangkok pays attention to. The intention is to raise the level of public health services by applying technology, which is the Don’t Wait. Get Checked. project from AstraZeneca. that uses AI technology to increase the efficiency of lung cancer screening
Initially, it has answered the question and delivered concrete results in supporting Bangkok’s policies under the Bangkok Health Zoning project through Preventive Urban Medicine (disease prevention for people in urban areas) to promote, prevent, and resolve risks that are threats. health and promote knowledge to the community at the capillary level This will help reduce inequality so that everyone can Access to treatment faster and more equitably The results of the research in this project in Bangkok will be taken into consideration in order to lead to Bangkok’s health policy.
.
Target for screening 5 hundred thousand people in 2024
.
Mr. Roman Ramos, President of AstraZeneca Thailand, said AstraZeneca Committed to improving the quality of life of patients Through the use of scientific advancements to expand and develop sustainable health care for people, communities, and the world. Cancer is considered one of the main disease groups that has been given continuous importance.
We have researched, invented, and supported innovations that will help improve the efficiency of early disease diagnosis through the use of AI technology. This approach is consistent with the current public health path of Thailand. who want to create innovations and move towards digital health care From this cooperation Set a goal to provide primary lung cancer screening to more than 500,000 people by 2024 in order to increase the chance of survival for patients.
For AI technology or qXR software installed in this project It was developed by Qure.ai, an AI solutions company that is one of AstraZeneca’s partners. that supports the use of technology and innovation to help develop lung cancer screening in the early stages This solution has been registered by the Food and Drug Administration. To be an artificial intelligence medical tool that uses deep learning capabilities to identify up to 29 abnormalities from lung X-ray images, including the size and location of lumps. or signs of symptoms that may accurately indicate lung cancer
Mr. Prashant Warrior, CEO and co-founder of Qure.ai, said that leveraging Qure’s cutting-edge AI technology, qXR, will analyze chest X-ray images. This is part of the initial screening program to identify lung cancer risk. It plays an important role in detecting lung nodules. This may be an indicator of lung cancer in the early stages. Once a suspicious lung mass has been identified Patients will undergo a CT scan immediately for further diagnosis and timely treatment planning.
Mobile screening point and affiliated hospitals in Bangkok
Charoenkrung Pracharak Hospital
Sirindhorn Hospital
Rajphiphat Hospital
Luangphor Thaweesak Chutintharo Uthit Hospital
Lat Krabang Hospital, Bangkok
Mobile health inspection unit, Department of Health
Chatchart Sitthiphan, Governor of Bangkok
Roman Ramos, Chairman of AstraZeneca (Thailand) Co., Ltd.
Signing of cooperation to expand the “Don’t Wait. Get Checked.” project between Bangkok and AstraZeneca (Thailand) Company Limited.
2023-10-18 02:37:00
#Bangkok #joins #AstraZeneca #Proactive #screening #lung #cancer #technology
